European Medical Solutions (STU:AS00) EPS without NRI: €0.44 (TTM As of Dec. 2025)


STU:AS00 European Medical Solutions STU:AS00
48 GF Score
Price €4.70
GF Value €8.16
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions EPS without NRI?

European Medical Solutions STU:AS00 -0.42% 48 EPS without NRI is €0.44 as of Dec. 2025. GuruFocus rates STU:AS00 with a GF Score™ of 48/100 and a GF Value™ of €8.16. The stock has 2 warning signs investors should review. Among 1,166 Biotechnology companies, European Medical Solutions ranks worse than 85763.21% on this metric.

European Medical Solutions's earnings per share without non-recurring items for the six months ended in Dec. 2025 was €0.20. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was €0.44.

During the past 12 months, European Medical Solutions's average earnings per share (NRI) Growth Rate was 237.20% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for European Medical Solutions's EPS without NRI or its related term are showing as below:

During the past 13 years, European Medical Solutions's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 88.00% per year. The lowest was -59.20% per year. And the median was 36.85% per year.

STU:AS00's 3-Year EPS without NRI Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 16.65
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

European Medical Solutions's EPS (Diluted) for the six months ended in Dec. 2025 was €0.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.44.

European Medical Solutions's EPS (Basic) for the six months ended in Dec. 2025 was €0.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.44.


European Medical Solutions  (STU:AS00) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


European Medical Solutions EPS without NRI Related Terms


European Medical Solutions EPS without NRI Historical Data

* Premium members only.

The historical data trend for European Medical Solutions's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Medical Solutions EPS without NRI Chart

European Medical Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.52 -0.47 -0.18 0.13 0.44

European Medical Solutions Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.35 -0.02 0.06 0.23 0.20

STU:AS00 vs VRTX, REGN, ALNY: EPS without NRI Comparison

For the Biotechnology subindustry, European Medical Solutions's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


European Medical Solutions PE Ratio without NRI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, European Medical Solutions's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where European Medical Solutions's PE Ratio without NRI falls into.


STU:AS00
48GF Score
European Medical Solutions STU:AS00
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

European Medical Solutions EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €0.44 mean?
European Medical Solutions (STU:AS00) has a EPS without NRI of €0.44 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on European Medical Solutions and its competitors. According to the industry distribution chart, European Medical Solutions ranks #999999 out of 1166 companies in the Biotechnology industry.
Is European Medical Solutions' EPS without NRI too high?
European Medical Solutions' current EPS without NRI is €0.44. Based on the distribution chart, European Medical Solutions ranks #999999 out of 1166 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, European Medical Solutions has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' EPS without NRI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, European Medical Solutions ranks #999999 out of 1166 companies for EPS without NRI. This places European Medical Solutions in the lower half of its industry. The industry median EPS without NRI is 16.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Biotechnology company?
The median EPS without NRI among Biotechnology companies is 16.65, based on 1,166 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on European Medical Solutions and its competitors. For the Biotechnology industry, the median EPS without NRI is 16.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. European Medical Solutions's current EPS without NRI is €0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current EPS without NRI of €0.44. The stock's GF Value™ is €8.16, compared to a current price of €4.70 — trading 42.4% below its estimated fair value. The current EPS without NRI is €0.44. European Medical Solutions' overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current EPS without NRI is €0.44 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is European Medical Solutions (STU:AS00) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.70 is trading 42.4% below its estimated GF Value™ of €8.16.

Key valuation signals for STU:AS00:

  • EPS without NRI: €0.44
  • GF Value™: €8.16 vs. price of €4.70 (42.4% below fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
48GF Score

Get the complete analysis for STU:AS00

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.70
Price
€8.16
GF Value